id stringlengths 20 43 | track stringclasses 4
values | question stringlengths 83 200 | required_claims listlengths 2 4 | certainty stringlengths 64 464 | scope stringlengths 47 322 | wrong_if stringlengths 49 281 ⌀ | gold stringlengths 736 1.55k | doi stringlengths 12 35 | access stringclasses 2
values |
|---|---|---|---|---|---|---|---|---|---|
steered/10.1136/openhrt-2026-003979 | cardiology | What does a CT-derived fractional flow reserve at or below 0.80 mean for future major adverse cardiovascular events? | [
"A CT-derived fractional flow reserve at or below 0.80 marks a patient at roughly four times the risk of major adverse cardiovascular events compared with a value above it",
"the signal is most consistent when the outcome is restricted to death or myocardial infarction, where the studies agree almost exactly, whe... | The prognostic association is strong and consistent across most of the evidence but directly contested by one part of it. | applies to suspected or known coronary artery disease assessed by coronary CT angiography in adults undergoing CT-derived fractional flow reserve assessment, outpatient settings | it states that the size of the association differed by the software used or between Western and Asian populations | A strong answer conveys: A CT-derived fractional flow reserve at or below 0.80 marks a patient at roughly four times the risk of major adverse cardiovascular events compared with a value above it; the signal is most consistent when the outcome is restricted to death or myocardial infarction, where the studies agree alm... | 10.1136/openhrt-2026-003979 | open |
steered/10.1002/clc.70369 | cardiology | In patients after percutaneous coronary intervention, how does moderate-intensity statin plus ezetimibe compare with high-intensity statin monotherapy? | [
"Substituting a moderate-intensity statin with ezetimibe for a high-intensity statin is not associated with a different overall rate of major adverse cardiovascular events, and repeat revascularisation rates are likewise similar between the two strategies",
"A modest reduction in cardiovascular mortality was obse... | The equivalence is a consistent association across the available evidence, while the component advantages remain unreliable. | applies to atherosclerotic coronary disease treated with percutaneous coronary intervention in adults after percutaneous coronary intervention requiring lipid-lowering therapy, outpatient settings | it presents the reductions in cardiovascular death or myocardial infarction with the combination as an established advantage that should decide which regimen is used | A strong answer conveys: Substituting a moderate-intensity statin with ezetimibe for a high-intensity statin is not associated with a different overall rate of major adverse cardiovascular events, and repeat revascularisation rates are likewise similar between the two strategies; A modest reduction in cardiovascular mo... | 10.1002/clc.70369 | open |
steered/10.1136/bmjopen-2025-115027 | cardiology | What is known about giving a fibrinolytic drug into the coronary artery when flow fails to return during primary percutaneous coronary intervention for ST-elevation myocardial infarction? | [
"intracoronary prourokinase given when flow fails to return improved coronary flow and myocardial perfusion compared with placebo, with complete ST-segment resolution in roughly two-thirds of patients against under half",
"peak creatine kinase-MB, a marker of myocardial damage, was lower with the intracoronary fi... | This is an early signal from a single randomised comparison rather than a settled effect on patient outcomes. | applies to slow flow or no-reflow arising during primary percutaneous coronary intervention for ST-elevation myocardial infarction in adults with ST-elevation myocardial infarction who develop slow flow or no-reflow during percutaneous coronary intervention, inpatient settings | it presents the flow and perfusion benefit as demonstrated across the full range of acute coronary syndrome presentations rather than in ST-elevation infarction alone | A strong answer conveys: intracoronary prourokinase given when flow fails to return improved coronary flow and myocardial perfusion compared with placebo, with complete ST-segment resolution in roughly two-thirds of patients against under half; peak creatine kinase-MB, a marker of myocardial damage, was lower with the ... | 10.1136/bmjopen-2025-115027 | open |
steered/10.1111/jce.70362 | cardiology | What outcomes follow left atrial appendage occlusion performed without contrast injection compared with contrast-guided implantation? | [
"closing the left atrial appendage without any contrast injection achieves procedural success and short-term safety on a par with the contrast-guided approach (success in nearly every case either way)",
"sealing of the appendage, device-related thrombus and thromboembolic events through the first year are similar... | The similarity between the two approaches is a consistent observation rather than an established equivalence. | applies to atrial fibrillation with an indication for left atrial appendage occlusion in adults undergoing percutaneous left atrial appendage occlusion, inpatient settings | it presents the two approaches as having been assigned rather than chosen by the operator, or the comparability as established rather than observed | A strong answer conveys: closing the left atrial appendage without any contrast injection achieves procedural success and short-term safety on a par with the contrast-guided approach (success in nearly every case either way); sealing of the appendage, device-related thrombus and thromboembolic events through the first ... | 10.1111/jce.70362 | open |
steered/10.1177/10742484261456161 | cardiology | How does norepinephrine compare with dopamine as initial vasoactive therapy for mortality in cardiogenic shock? | [
"death within four weeks was about as common whether norepinephrine or dopamine was the first vasoactive agent, and the uncertainty around that comparison is wide enough to leave a real difference in either direction possible",
"the need to add rescue epinephrine was also comparable between the two agents",
"a ... | The absence of a detectable difference between the two agents is an observation from care as it was given, not a demonstration that the agents are equivalent. | applies to cardiogenic shock in adults requiring an initial vasoactive agent in a coronary care setting, inpatient settings | it treats the link between epinephrine use and death as harm done by epinephrine, since that use marked resuscitation and overall illness severity rather than a drug effect | A strong answer conveys: death within four weeks was about as common whether norepinephrine or dopamine was the first vasoactive agent, and the uncertainty around that comparison is wide enough to leave a real difference in either direction possible; the need to add rescue epinephrine was also comparable between the tw... | 10.1177/10742484261456161 | open |
steered/10.1002/clc.70377 | cardiology | Which nocturnal blood pressure patterns relate to major adverse cardiovascular events during the year after anterior STEMI? | [
"A reversed overnight pattern, in which blood pressure rises at night instead of falling, is associated with substantially more major adverse cardiovascular events over the following year than a normal nocturnal fall (a several-fold higher hazard)",
"A merely blunted nocturnal fall, or an exaggerated one, is not ... | The link is an association carrying wide uncertainty around its size, not a demonstrated cause of the events. | applies to anterior ST-elevation myocardial infarction treated with emergency percutaneous coronary intervention in adults after emergency percutaneous coronary intervention for anterior ST-elevation myocardial infarction, inpatient settings | it presents timing antihypertensive treatment to restore the overnight fall as shown to improve outcomes | A strong answer conveys: A reversed overnight pattern, in which blood pressure rises at night instead of falling, is associated with substantially more major adverse cardiovascular events over the following year than a normal nocturnal fall (a several-fold higher hazard); A merely blunted nocturnal fall, or an exaggera... | 10.1002/clc.70377 | open |
steered/10.1111/jce.70366 | cardiology | Among patients with newly diagnosed left ventricular dysfunction and a sustained arrhythmia whose rhythm is successfully controlled, what proportion turn out to have arrhythmia-induced cardiomyopathy? | [
"among patients who maintained sinus rhythm or suppressed ectopy after rhythm control, roughly three in five met the criteria for a reversible arrhythmia-induced cardiomyopathy",
"the observed proportion aligns with rates between 50% and 82% reported in previous series",
"no measurable feature at presentation, ... | This is a counted proportion carrying real uncertainty in both directions rather than a settled figure. | applies to newly diagnosed left ventricular systolic dysfunction with a concurrent sustained arrhythmia in adults with newly diagnosed idiopathic left ventricular systolic dysfunction severe enough to warrant a wearable defibrillator, with atrial fibrillation, atrial flutter or frequent ventricular ectopy, mixed settin... | it states that the defibrillator indication persisted in most patients after rhythm control | A strong answer conveys: among patients who maintained sinus rhythm or suppressed ectopy after rhythm control, roughly three in five met the criteria for a reversible arrhythmia-induced cardiomyopathy; the observed proportion aligns with rates between 50% and 82% reported in previous series; no measurable feature at pr... | 10.1111/jce.70366 | open |
steered/10.1136/openhrt-2026-004054 | cardiology | How does adding angina to the H₂FPEF score change identification of HFpEF in women? | [
"counting exertional chest pain as an extra item in the score identifies more of the women who turn out to have the condition, while the score stays well calibrated",
"the improvement in how well the score separates women with and without the condition is modest (a small rise in discrimination), so the change ref... | The improvement is an early finding taken from the same data in which the change was devised, and has not been confirmed elsewhere. | applies to suspected heart failure with preserved ejection fraction in women older than sixty being assessed for unexplained breathlessness, primary care settings | it treats angina in these women as a marker of obstructive coronary disease, since obstructive disease does not account for the whole burden of angina in this condition | A strong answer conveys: counting exertional chest pain as an extra item in the score identifies more of the women who turn out to have the condition, while the score stays well calibrated; the improvement in how well the score separates women with and without the condition is modest (a small rise in discrimination), s... | 10.1136/openhrt-2026-004054 | open |
steered/10.1002/clc.70344 | cardiology | How does the blood urea to creatinine ratio relate to outcomes in patients with heart failure? | [
"a higher blood urea to creatinine ratio marks patients with heart failure who go on to die sooner, and the signal is strongest in those with preserved ejection fraction (where the gap is roughly threefold)",
"a raised ratio also tracks with worse symptom class and with more early cardiovascular events, but not w... | The link between a higher ratio and worse outcome is a repeated association of low certainty, not an established cause. | applies to adults with heart failure across the ejection fraction range, mixed settings | it presents the reported risk estimates as pooled figures, since heterogeneity and missing extractable data prevented statistical pooling and the findings were combined descriptively | A strong answer conveys: a higher blood urea to creatinine ratio marks patients with heart failure who go on to die sooner, and the signal is strongest in those with preserved ejection fraction (where the gap is roughly threefold); a raised ratio also tracks with worse symptom class and with more early cardiovascular e... | 10.1002/clc.70344 | open |
steered/10.1111/1440-1681.70142 | cardiology | Which markers of hypertension-mediated organ damage warrant assessment when stratifying cardiovascular risk in hypertensive patients? | [
"left ventricular hypertrophy predicts adverse cardiovascular outcomes over and above the hypertension itself",
"risk rises continuously across the range of left ventricular mass, including below the conventional thresholds for hypertrophy",
"A concentric pattern of left ventricular remodelling indicates pressu... | These are consistent prognostic associations rather than effects of the damage itself being demonstrated. | applies to adults with hypertension undergoing cardiovascular risk stratification, outpatient settings | it presents regression of ventricular hypertrophy with intensive blood pressure lowering as a definitive and consistent finding | A strong answer conveys: left ventricular hypertrophy predicts adverse cardiovascular outcomes over and above the hypertension itself; risk rises continuously across the range of left ventricular mass, including below the conventional thresholds for hypertrophy; A concentric pattern of left ventricular remodelling indi... | 10.1111/1440-1681.70142 | paywalled |
steered/10.1111/ctr.70569 | cardiology | What one-year survival follows heart transplantation from donation after circulatory death donors in recipients with prior cardiac surgery? | [
"one-year survival after a circulatory-death donor heart transplant is close to nine in ten in recipients with previous conventional cardiac surgery, lower than in recipients without such surgery",
"the lower survival persisted after propensity score matching on measured risk factors",
"within the group with pr... | These are consistent associations rather than effects established by direct comparison. | applies to end-stage heart failure treated by heart transplantation from a circulatory-death donor in adults with previous conventional cardiac surgery, excluding those supported by a durable ventricular assist device or with previous congenital heart surgery, inpatient settings | it presents the survival deficit as a reason to withhold circulatory-death donor hearts from recipients with previous cardiac surgery | A strong answer conveys: one-year survival after a circulatory-death donor heart transplant is close to nine in ten in recipients with previous conventional cardiac surgery, lower than in recipients without such surgery; the lower survival persisted after propensity score matching on measured risk factors; within the g... | 10.1111/ctr.70569 | open |
steered/10.1002/clc.70446 | cardiology | What do changes in urinary albumin to creatinine ratio over time indicate about outcomes in heart failure with preserved ejection fraction? | [
"a urinary albumin to creatinine ratio that stays high and swings about over repeated measurements marks patients whose risk of cardiovascular death, cardiac arrest or heart failure admission is raised (roughly doubled)",
"a ratio that falls over time does not carry that excess risk, and its apparent link with my... | The link between the albuminuria pattern and later events is a consistent association rather than an established cause. | applies to adults with symptomatic heart failure and preserved ejection fraction undergoing repeated albuminuria measurement, outpatient settings | it recommends treating to bring the albumin to creatinine ratio down as a way of preventing these events, since the patterns were observed rather than assigned and no attempt to change the ratio was tested | A strong answer conveys: a urinary albumin to creatinine ratio that stays high and swings about over repeated measurements marks patients whose risk of cardiovascular death, cardiac arrest or heart failure admission is raised (roughly doubled); a ratio that falls over time does not carry that excess risk, and its appar... | 10.1002/clc.70446 | open |
steered/10.1136/bmjopen-2025-108331 | cardiology | In Chinese adults admitted with moderate-to-severe valvular heart disease, how does management differ between men and women? | [
"men were significantly more likely than women to undergo coronary angiography",
"among patients with atrial fibrillation or flutter, women were more likely than men to receive warfarin",
"whether women are less likely to receive valve intervention is disputed: one cohort found no difference in the overall inte... | The treatment findings are consistently described within one cohort, while the difference in access to valve intervention is actively contested. | applies to moderate-to-severe valvular heart disease in adults admitted to tertiary and referral cardiovascular centres in China, inpatient settings | it attributes the pattern of valve intervention by sex to a specific cause such as patient refusal | A strong answer conveys: men were significantly more likely than women to undergo coronary angiography; among patients with atrial fibrillation or flutter, women were more likely than men to receive warfarin; whether women are less likely to receive valve intervention is disputed: one cohort found no difference in the ... | 10.1136/bmjopen-2025-108331 | open |
steered/10.1002/clc.70312 | cardiology | Which characteristics of patients receiving immune checkpoint inhibitors relate to developing myocarditis? | [
"older age, male sex, hypertension and hyperlipidaemia all mark patients on checkpoint inhibitors as more likely to be flagged with myocarditis",
"tumour type matters as well, with thymic tumours carrying the highest odds (roughly doubled) and lung cancer a smaller rise, and blocking more than one checkpoint addi... | These characteristics mark who is more likely to be flagged, and are associations from care as it was delivered rather than established causes. | applies to myocarditis during immune checkpoint inhibitor therapy in adults receiving an immune checkpoint inhibitor for cancer, mixed settings | it lists diabetes among the characteristics carrying extra risk, since it did not hold up once the other characteristics were accounted for | A strong answer conveys: older age, male sex, hypertension and hyperlipidaemia all mark patients on checkpoint inhibitors as more likely to be flagged with myocarditis; tumour type matters as well, with thymic tumours carrying the highest odds (roughly doubled) and lung cancer a smaller rise, and blocking more than one... | 10.1002/clc.70312 | open |
steered/10.1002/clc.70398 | cardiology | What is known about the effect of ethanol infusion into the vein of Marshall on achieving durable mitral isthmus block? | [
"ethanol delivered into the vein of Marshall is associated with durable bidirectional mitral isthmus block being achieved more often than with radiofrequency ablation alone",
"whether the improvement in block translates into fewer arrhythmia recurrences is disputed, with a randomised trial and pooled analyses rep... | The gain in block is consistent across the evidence, while the gain in arrhythmia outcomes is actively contested. | applies to persistent atrial fibrillation or mitral isthmus-dependent atrial tachycardia undergoing catheter ablation in adults undergoing catheter ablation in whom mitral isthmus block is intended, inpatient settings | it presents the reduction in arrhythmia recurrence as established for paroxysmal atrial fibrillation as well as for persistent atrial fibrillation | A strong answer conveys: ethanol delivered into the vein of Marshall is associated with durable bidirectional mitral isthmus block being achieved more often than with radiofrequency ablation alone; whether the improvement in block translates into fewer arrhythmia recurrences is disputed, with a randomised trial and poo... | 10.1002/clc.70398 | open |
steered/10.1136/heartjnl-2025-326694 | cardiology | Which imaging modalities establish cardiac sarcoidosis when endomyocardial biopsy is negative or not feasible? | [
"cardiovascular magnetic resonance is the test to reach for first, because absence of late gadolinium enhancement reduces the possibility of clinically significant disease",
"magnetic resonance carries the better prognostic information for arrhythmic risk and cardiac mortality",
"metabolic imaging with fluorode... | These are consistent associations rather than established test characteristics. | applies to suspected cardiac sarcoidosis with negative or unobtainable endomyocardial biopsy in adults with suspected cardiac sarcoidosis, with or without known extracardiac disease, mixed settings | it states that a normal fluorodeoxyglucose positron emission tomography study excludes cardiac sarcoidosis | A strong answer conveys: cardiovascular magnetic resonance is the test to reach for first, because absence of late gadolinium enhancement reduces the possibility of clinically significant disease; magnetic resonance carries the better prognostic information for arrhythmic risk and cardiac mortality; metabolic imaging w... | 10.1136/heartjnl-2025-326694 | paywalled |
steered/10.1136/bmj-2023-078952 | cardiology | How do transcatheter and surgical aortic valve replacement compare over longer follow-up in low surgical risk patients with aortic stenosis? | [
"the early advantage of the transcatheter approach over surgery in low-risk patients does not hold: by seven years the composite of death, stroke and repeat hospital stay is no longer separated, although the early gap was roughly a halving of events",
"reintervention on the valve moves the other way with longer f... | The differences between the two procedures can be read as caused by which procedure the patient was assigned to receive. | applies to severe aortic stenosis in adults at low surgical risk undergoing aortic valve replacement, inpatient settings | it attributes the early advantage of the transcatheter approach to fewer deaths, since it was driven mainly by fewer repeat hospital stays | A strong answer conveys: the early advantage of the transcatheter approach over surgery in low-risk patients does not hold: by seven years the composite of death, stroke and repeat hospital stay is no longer separated, although the early gap was roughly a halving of events; reintervention on the valve moves the other w... | 10.1136/bmj-2023-078952 | paywalled |
steered/10.1002/cam4.71682 | cardiology | How should cancer therapy related cardiac dysfunction be assessed and managed without interrupting effective cancer treatment? | [
"cardiac risk is graded before cardiotoxic treatment begins, and biomarker and imaging surveillance is then pitched to that baseline risk rather than applied uniformly",
"a fall in ejection fraction without symptoms is not on its own a reason to stop effective cancer treatment: cardioprotective medication is star... | These are expert recommendations assembled from existing guidance, not a comparison of one management pathway against another. | applies to cancer therapy related cardiac dysfunction in adults receiving potentially cardiotoxic cancer treatment, outpatient settings | it says that adding a cardioprotective agent to reduce heart failure costs cancer control, since response, overall survival and progression-free survival were all unaffected | A strong answer conveys: cardiac risk is graded before cardiotoxic treatment begins, and biomarker and imaging surveillance is then pitched to that baseline risk rather than applied uniformly; a fall in ejection fraction without symptoms is not on its own a reason to stop effective cancer treatment: cardioprotective me... | 10.1002/cam4.71682 | open |
steered/10.1136/openhrt-2025-003954 | cardiology | What clinical outcomes follow conduction system pacing versus right ventricular pacing in patients with atrioventricular block? | [
"conduction system pacing is associated with preservation of left ventricular ejection fraction, with less decline than right ventricular pacing",
"paced QRS complexes are markedly shorter with conduction system pacing than with right ventricular pacing",
"whether that translates into fewer heart failure admiss... | The advantage in ventricular function and activation is consistent, while the effect on admissions and survival is contested within the randomised evidence itself. | applies to atrioventricular block requiring ventricular pacing in adults receiving a pacemaker for atrioventricular block, including those with preserved ventricular function, mixed settings | it presents the reduction in a composite endpoint as showing that conduction system pacing reduces mortality | A strong answer conveys: conduction system pacing is associated with preservation of left ventricular ejection fraction, with less decline than right ventricular pacing; paced QRS complexes are markedly shorter with conduction system pacing than with right ventricular pacing; whether that translates into fewer heart fa... | 10.1136/openhrt-2025-003954 | open |
steered/10.1136/jnis-2025-024031 | neuroimmunology | What changes occur in peripheral leukocyte and lymphocyte subsets after in situ ischemic postconditioning during thrombectomy? | [
"patients who received in situ ischemic postconditioning during thrombectomy had a higher helper-to-cytotoxic T-cell ratio than propensity-matched external controls",
"the same patients had a lower proportion of natural killer cells than the matched controls",
"total lymphocyte counts were numerically higher in... | These immune shifts are preliminary signals rather than confirmed effects. | applies to acute ischemic stroke from large vessel occlusion in adults undergoing mechanical thrombectomy, inpatient settings | it reports that overall infarct volume at seventy-two hours was significantly reduced | A strong answer conveys: patients who received in situ ischemic postconditioning during thrombectomy had a higher helper-to-cytotoxic T-cell ratio than propensity-matched external controls; the same patients had a lower proportion of natural killer cells than the matched controls; total lymphocyte counts were numerical... | 10.1136/jnis-2025-024031 | paywalled |
steered/10.1177/17562864261421717 | neuroimmunology | How does antibody subtype relate to the response to ofatumumab in refractory generalised myasthenia gravis? | [
"in a small retrospective early series, minimal symptom expression was reached by more of the muscle-specific-kinase patients than the acetylcholine-receptor patients, and after a shorter median time",
"the unadjusted comparison of time to minimal symptom expression did not reach statistical significance",
"the... | This is an observation in twenty-one patients rather than a demonstrated subtype difference. | applies to refractory generalised myasthenia gravis in adults treated with anti-CD20 therapy grouped by antibody type, specialist outpatient settings | it states that memory B-cell counts reliably predict imminent relapse and can be used as a retreatment trigger | A strong answer conveys: in a small retrospective early series, minimal symptom expression was reached by more of the muscle-specific-kinase patients than the acetylcholine-receptor patients, and after a shorter median time; the unadjusted comparison of time to minimal symptom expression did not reach statistical signi... | 10.1177/17562864261421717 | open |
steered/10.1002/mus.70211 | neuroimmunology | What comorbidity burden accumulates in the years following a myasthenia gravis diagnosis in adults? | [
"cardiovascular conditions, above all hypertension, are the commonest coexisting illnesses already before the diagnosis is made and remain prominent afterwards",
"in the years after diagnosis the burden shifts, with anaemia, osteoporosis and cataract becoming several times more common than beforehand, a pattern t... | These are consistent descriptive patterns rather than demonstrated effects of the disease or its treatment. | applies to myasthenia gravis in adults followed from diagnosis in national health registries, population-based settings | it states that the post-diagnosis rise was shown to be caused by treatment | A strong answer conveys: cardiovascular conditions, above all hypertension, are the commonest coexisting illnesses already before the diagnosis is made and remain prominent afterwards; in the years after diagnosis the burden shifts, with anaemia, osteoporosis and cataract becoming several times more common than beforeh... | 10.1002/mus.70211 | open |
steered/10.1136/lupus-2025-001643 | neuroimmunology | What does translocator protein positron emission tomography show when lupus with neuropsychiatric involvement is compared with lupus without it? | [
"peak tracer uptake was significantly higher in patients with neuropsychiatric involvement than in those without, while mean uptake across the region was not",
"peak uptake correlated with damage index, disability scale and disease activity scores, while mean uptake showed no significant correlation with any of t... | This is an early signal in a small sample rather than a validated diagnostic test. | applies to systemic lupus erythematosus with neuropsychiatric involvement in adults undergoing translocator protein positron emission tomography, specialist outpatient settings | it presents this imaging as a validated diagnostic test or as having replaced clinical criteria | A strong answer conveys: peak tracer uptake was significantly higher in patients with neuropsychiatric involvement than in those without, while mean uptake across the region was not; peak uptake correlated with damage index, disability scale and disease activity scores, while mean uptake showed no significant correlati... | 10.1136/lupus-2025-001643 | open |
steered/10.1177/17562864261429570 | neuroimmunology | What clinical responses follow CD19 CAR T-cell therapy in refractory myasthenia gravis and other antibody-mediated neurological autoimmune diseases? | [
"in refractory myasthenia gravis, CD19-directed cell therapy was followed by long-term remission with stable immunoglobulin G concentrations in the two patients reported",
"in a small single-arm study of RNA-engineered BCMA-directed cells, most of the treated myasthenia patients still showed improvement in activi... | The responses are striking but early, and confirmation is still outstanding. | applies to refractory antibody-mediated neurological autoimmune disease in adults who have failed available immunotherapies, specialist cell-therapy centre settings | it states the therapy carries no neurological toxicity | A strong answer conveys: in refractory myasthenia gravis, CD19-directed cell therapy was followed by long-term remission with stable immunoglobulin G concentrations in the two patients reported; in a small single-arm study of RNA-engineered BCMA-directed cells, most of the treated myasthenia patients still showed impro... | 10.1177/17562864261429570 | open |
steered/10.1177/13524585261418536 | neuroimmunology | How does concomitant corticosteroid tapering proceed in patients with NMOSD starting satralizumab in routine care? | [
"once interleukin-6 receptor blockade is started, the oral corticosteroid is the medication clinicians bring down first, and it is stopped altogether in about half of patients over two and a half years",
"non-steroidal immunosuppressants come down more slowly and unevenly, with azathioprine withdrawn in most pati... | This describes observed practice and its outcomes rather than a tested tapering strategy. | applies to aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder in patients starting interleukin-6 receptor blockade in routine care, outpatient settings | it says discontinuations of the biologic were driven by inadequate effect rather than tolerability | A strong answer conveys: once interleukin-6 receptor blockade is started, the oral corticosteroid is the medication clinicians bring down first, and it is stopped altogether in about half of patients over two and a half years; non-steroidal immunosuppressants come down more slowly and unevenly, with azathioprine withdr... | 10.1177/13524585261418536 | open |
steered/10.1177/13524585251409581 | neuroimmunology | What patient characteristics mark AQP4-IgG NMOSD patients at risk of severe or opportunistic infections during immunosuppression? | [
"severe or opportunistic infection reaches a substantial minority of patients on long-term immunosuppression and accounts for about a third of deaths",
"older age at onset, longer time with the disease, a coexisting autoimmune condition and diabetes each mark higher infection risk once the other factors are accou... | These are associations that identify higher-risk patients rather than established causes. | applies to aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder on long-term immunosuppression in adults followed for at least a year, specialist outpatient settings | it presents the number of immunosuppressants or total treatment duration as an independent predictor | A strong answer conveys: severe or opportunistic infection reaches a substantial minority of patients on long-term immunosuppression and accounts for about a third of deaths; older age at onset, longer time with the disease, a coexisting autoimmune condition and diabetes each mark higher infection risk once the other f... | 10.1177/13524585251409581 | paywalled |
steered/10.1177/17562864261433329 | neuroimmunology | How do serum NfL and GFAP concentrations behave during attacks and remission in NMOSD and MOGAD? | [
"in aquaporin-4 antibody disease both the axonal and the astrocyte marker rise during attacks and settle again in remission, with z-score cut-offs proposed to separate the two states",
"in myelin oligodendrocyte glycoprotein antibody disease the axonal marker is raised, highest during attacks, fluctuating over th... | The attack-related rise is well supported, while the astrocyte marker in myelin oligodendrocyte glycoprotein antibody disease remains genuinely disputed. | applies to aquaporin-4 antibody neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein antibody-associated disease in patients sampled during attacks and in remission, specialist neurology settings | it states that the astrocyte marker runs higher in myelin oligodendrocyte glycoprotein antibody disease than in aquaporin-4 antibody disease | A strong answer conveys: in aquaporin-4 antibody disease both the axonal and the astrocyte marker rise during attacks and settle again in remission, with z-score cut-offs proposed to separate the two states; in myelin oligodendrocyte glycoprotein antibody disease the axonal marker is raised, highest during attacks, flu... | 10.1177/17562864261433329 | open |
steered/10.1177/08830738251356122 | neuroimmunology | What outcomes follow therapeutic plasma exchange combined with methylprednisolone in children with severe autoimmune encephalitis? | [
"most children still carry substantial functional limitation when they leave hospital, after a median stay of well over a month",
"only a minority still carry substantial functional limitation at follow-up of a year or more, so recovery unfolds over months rather than weeks",
"starting the exchange within the f... | These are early uncontrolled observations, and the regimen question is left open by the material itself. | applies to severe autoimmune encephalitis in children treated with plasma exchange during the acute admission, inpatient settings | it presents the combination of methylprednisolone with exchange as demonstrated superior to exchange alone | A strong answer conveys: most children still carry substantial functional limitation when they leave hospital, after a median stay of well over a month; only a minority still carry substantial functional limitation at follow-up of a year or more, so recovery unfolds over months rather than weeks; starting the exchange ... | 10.1177/08830738251356122 | paywalled |
steered/10.1177/20552173251406973 | neuroimmunology | What burden do repeated NMOSD relapses place on patient disability, quality of life, and caregivers? | [
"bladder and bowel control problems were more common in patients who had relapsed than in those who had not, and became more common with additional relapses",
"impact on daily living was high throughout, with over half of patients affected in their ability to work or drive, and significantly more of those with a ... | The burden findings are associations, and the quality-of-life result is in genuine tension with other evidence. | applies to aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder in adults under neurologist care with or without relapses since the initial attack, outpatient settings | it states that relapses caused the disability and burden, since the design is cross-sectional and supports associations only | A strong answer conveys: bladder and bowel control problems were more common in patients who had relapsed than in those who had not, and became more common with additional relapses; impact on daily living was high throughout, with over half of patients affected in their ability to work or drive, and significantly more ... | 10.1177/20552173251406973 | open |
steered/10.1177/13524585251370884 | neuroimmunology | How do peripheral immune cells reach the CNS compartment and sustain tissue injury in multiple sclerosis? | [
"Peripheral immune cells reach the central nervous system by more than one route: across the blood-brain barrier, across the blood-cerebrospinal-fluid barrier at the choroid plexus, and directly through dura-associated meningeal channels",
"Cells and immune mediators accumulating in meningeal and perivascular nic... | This is a well-supported account of the mechanism, with the treatment-timing element an association rather than a demonstrated comparative effect. | applies to multiple sclerosis in patients across relapsing and progressive disease, specialist neurology settings | it claims the animal model mechanisms translate uniformly to patients | A strong answer conveys: Peripheral immune cells reach the central nervous system by more than one route: across the blood-brain barrier, across the blood-cerebrospinal-fluid barrier at the choroid plexus, and directly through dura-associated meningeal channels; Cells and immune mediators accumulating in meningeal and ... | 10.1177/13524585251370884 | open |
steered/10.1177/00368504251390710 | neuroimmunology | Which glial activation biomarkers in CSF or serum track astrocyte and microglial involvement in multiple sclerosis? | [
"Astrocyte involvement is tracked by glial fibrillary acidic protein and by S100 calcium-binding protein B, which is raised in both cerebrospinal fluid and serum at relapsing-remitting diagnosis and is concentrated in reactive astrocytes within active lesions",
"Microglial and macrophage activation is tracked by ... | The marker-to-cell-type mapping is reasonably supported but their clinical value remains unproven. | applies to multiple sclerosis in patients sampled in cerebrospinal fluid and serum, specialist neurology settings | it presents these markers as validated for routine clinical use | A strong answer conveys: Astrocyte involvement is tracked by glial fibrillary acidic protein and by S100 calcium-binding protein B, which is raised in both cerebrospinal fluid and serum at relapsing-remitting diagnosis and is concentrated in reactive astrocytes within active lesions; Microglial and macrophage activatio... | 10.1177/00368504251390710 | open |
steered/10.1002/mus.28450 | neuroimmunology | What clinical and serological profile do adults with myasthenia gravis show in multi-country observational registry cohorts? | [
"The enrolled population is predominantly older adults with a slight female majority and, at enrolment, a median disease duration of several years",
"Acetylcholine receptor antibodies are much the commonest serological group, with muscle-specific kinase antibodies a small minority, and a substantial minority pres... | This is a description of an enrolled population rather than a tested relationship. | applies to myasthenia gravis in adults enrolled in multi-country observational registries, specialist outpatient settings | it states that muscle-specific kinase antibody positive patients had markedly worse recorded outcomes than acetylcholine receptor antibody positive patients | A strong answer conveys: The enrolled population is predominantly older adults with a slight female majority and, at enrolment, a median disease duration of several years; Acetylcholine receptor antibodies are much the commonest serological group, with muscle-specific kinase antibodies a small minority, and a substanti... | 10.1002/mus.28450 | open |
steered/10.1177/08830738251396175 | neuroimmunology | Which clinical features at admission shape short-term prognosis in children with autoimmune encephalitis? | [
"poor short-term outcome is marked at admission by an abnormal brain scan, impaired consciousness, autonomic involvement, fever and a preceding infection, each carrying roughly three- to fourfold higher odds after adjustment",
"status epilepticus and a raised cerebrospinal fluid cell count separate the outcome gr... | These are associations with outcome rather than established causes, and the accuracy figure is apparent rather than validated. | applies to autoimmune encephalitis in children admitted with acute disease, inpatient settings | it reports a difference in age or sex between the outcome groups | A strong answer conveys: poor short-term outcome is marked at admission by an abnormal brain scan, impaired consciousness, autonomic involvement, fever and a preceding infection, each carrying roughly three- to fourfold higher odds after adjustment; status epilepticus and a raised cerebrospinal fluid cell count separat... | 10.1177/08830738251396175 | paywalled |
steered/10.1002/mus.70171 | neuroimmunology | Which clinical and antibody features distinguish corticosteroid-refractory juvenile myasthenia gravis from corticosteroid-responsive disease? | [
"acetylcholine receptor antibody positivity marks children less likely to be controlled by corticosteroids alone",
"isolated ptosis, and ocular-only disease more broadly, marks children more likely to respond to corticosteroids",
"most corticosteroid-refractory children respond once a nonsteroidal immunosuppres... | These are associations between baseline features and response group rather than demonstrated determinants. | applies to juvenile myasthenia gravis in children diagnosed before adolescence, specialist outpatient settings | it credits thymectomy with any of the improvement | A strong answer conveys: acetylcholine receptor antibody positivity marks children less likely to be controlled by corticosteroids alone; isolated ptosis, and ocular-only disease more broadly, marks children more likely to respond to corticosteroids; most corticosteroid-refractory children respond once a nonsteroidal i... | 10.1002/mus.70171 | paywalled |
steered/10.1177/0271678x261419964 | neuroimmunology | Which in vitro models capture microbiota effects on blood-brain barrier integrity for gut-brain axis research? | [
"barrier integrity is read out as electrical resistance across the cell layer and as leakage of fluorescent tracers, with falling resistance signalling a leakier barrier",
"complexity is added in steps, from two-dimensional transwell cultures to three-dimensional hydrogel and spheroid constructs that form tighter... | This describes established laboratory practice and the recognised limits of each model class. | applies to microbiota-gut-brain axis effects on blood-brain barrier integrity in cultured brain endothelial cells with pericytes, astrocytes and neural cells, co-cultured with microbial compartments, in vitro laboratory settings | it claims these findings transfer directly to the human barrier without in vivo work | A strong answer conveys: barrier integrity is read out as electrical resistance across the cell layer and as leakage of fluorescent tracers, with falling resistance signalling a leakier barrier; complexity is added in steps, from two-dimensional transwell cultures to three-dimensional hydrogel and spheroid constructs t... | 10.1177/0271678x261419964 | open |
steered/10.1002/advs.202519049 | neuroimmunology | Which second-line immunotherapies are used for refractory autoimmune encephalitis when antibody results remain pending in the ICU? | [
"when clinical suspicion is high and infection has been reasonably excluded, immunotherapy is started promptly rather than held back while antibody results are awaited",
"rituximab is the preferred second-line agent for suspected cell-surface-antibody and antibody-negative disease",
"cyclophosphamide is favoure... | This reflects settled practice for the sequencing question and unsettled evidence for the newer agents. | applies to autoimmune encephalitis in critically ill adults with suspected or refractory disease, intensive care settings | it states that a negative antibody panel excludes autoimmune encephalitis | A strong answer conveys: when clinical suspicion is high and infection has been reasonably excluded, immunotherapy is started promptly rather than held back while antibody results are awaited; rituximab is the preferred second-line agent for suspected cell-surface-antibody and antibody-negative disease; cyclophosphamid... | 10.1002/advs.202519049 | open |
steered/10.1177/15230864251401591 | neuroimmunology | In model systems of ischemic stroke, how do microglial phenotype shifts and cytokine release interact during the acute phase? | [
"in the acute phase after the vessel occludes, microglia activate rapidly and polarise toward a proinflammatory phenotype",
"those activated microglia release proinflammatory cytokines into the injured tissue, tumour necrosis factor alpha and interleukin-1 beta among them",
"those cytokines signal through nucle... | This is mechanistic evidence from model systems, consistent in direction but not established in patients. | applies to acute ischaemic stroke in rodent models of cerebral ischaemia-reperfusion and cultured microglia and endothelial cells, preclinical settings | null | A strong answer conveys: in the acute phase after the vessel occludes, microglia activate rapidly and polarise toward a proinflammatory phenotype; those activated microglia release proinflammatory cytokines into the injured tissue, tumour necrosis factor alpha and interleukin-1 beta among them; those cytokines signal t... | 10.1177/15230864251401591 | paywalled |
steered/10.1002/advs.202520313 | neuroimmunology | What determines clinical outcome in children with NMDA receptor antibody encephalitis? | [
"cerebrospinal fluid antibody titre is the measure that tracks outcome most closely, going with length of hospital stay and with disability from presentation through the first year",
"initial brain imaging is usually unremarkable and about half of first EEGs are normal, so there is no imaging signature of the dis... | These are things that go together in records reviewed after the fact, not effects of anything on outcome. | applies to children and adolescents diagnosed with NMDA receptor antibody encephalitis, mixed settings | it presents cerebrospinal fluid antibody titre as an established test for setting treatment intensity in an individual child | A strong answer conveys: cerebrospinal fluid antibody titre is the measure that tracks outcome most closely, going with length of hospital stay and with disability from presentation through the first year; initial brain imaging is usually unremarkable and about half of first EEGs are normal, so there is no imaging sign... | 10.1002/advs.202520313 | open |
steered/10.1136/jitc-2026-015176 | neuroimmunology | What is the long-term neurological course after immune checkpoint inhibitor-related neurological adverse events? | [
"recovery is only partial: about half of patients improve neurologically by three months, and among those still alive at one year roughly four in ten are left with neurological sequelae",
"further neurological improvement after the first year is rare and effectively stops after the second, so the deficit present ... | These are outcomes counted as they occurred and phenotypes compared after the fact, not effects of any assigned treatment. | applies to neurological immune-related adverse events of immune checkpoint inhibitors in adults treated with checkpoint inhibitors for cancer who develop moderate or severe neurological adverse events, mixed settings | it presents rechallenge with the checkpoint inhibitor as established to be safe after one of these events | A strong answer conveys: recovery is only partial: about half of patients improve neurologically by three months, and among those still alive at one year roughly four in ten are left with neurological sequelae; further neurological improvement after the first year is rare and effectively stops after the second, so the ... | 10.1136/jitc-2026-015176 | open |
steered/10.1002/clc.70225 | cardiology | How does loop diuretic therapy relate to mortality in patients with severe aortic stenosis undergoing valve replacement? | [
"Loop diuretic use before valve replacement is associated with roughly twice the long-term mortality of patients not taking one",
"This mortality signal is not explained by more severe stenosis, which is comparable in treated and untreated patients",
"Patients on a loop diuretic reach valve replacement with gre... | The evidence supports a consistent association rather than a causal effect, and the small number of deaths together with the older, more comorbid and higher-surgical-risk profile of treated patients weakens it further. | applies to severe aortic stenosis treated with aortic valve replacement in adults, inpatient settings | it advises weaning, withholding or stopping loop diuretic therapy around valve replacement as a way to reduce mortality | A strong answer conveys: Loop diuretic use before valve replacement is associated with roughly twice the long-term mortality of patients not taking one; This mortality signal is not explained by more severe stenosis, which is comparable in treated and untreated patients; Patients on a loop diuretic reach valve replacem... | 10.1002/clc.70225 | open |
steered/10.1007/s00134-025-08112-8 | cardiology | What is known about echocardiographic assessment of the left atrium when choosing rhythm control in critically ill patients with atrial fibrillation? | [
"Left atrial size, measured as the left atrial volume index, is a central echocardiographic input to the rhythm-versus-rate decision, with a non-dilated left atrium favouring an attempt at rhythm control",
"A dilated left atrium is associated with longstanding or recurrent atrial fibrillation and steers managemen... | These are preliminary observations from a small selected group and should not be read as general facts. | applies to new-onset or unknown-duration atrial fibrillation complicating critical illness in adults, inpatient settings | it states that selecting patients for rhythm control on the basis of left atrial size or function has been shown to improve survival | A strong answer conveys: Left atrial size, measured as the left atrial volume index, is a central echocardiographic input to the rhythm-versus-rate decision, with a non-dilated left atrium favouring an attempt at rhythm control; A dilated left atrium is associated with longstanding or recurrent atrial fibrillation and ... | 10.1007/s00134-025-08112-8 | open |
steered/10.1177/15385744251387547 | cardiology | What is known about bleeding risk with antithrombotic regimens after carotid stenting in patients with atrial fibrillation? | [
"Major bleeding within the first three months did not differ significantly between dual antiplatelet therapy, single antiplatelet plus oral anticoagulation, and triple therapy",
"Major bleeding was numerically least frequent with dual antiplatelet therapy alone and most frequent with triple therapy, a non-signifi... | The evidence is weak and preliminary, with far too few bleeding events to exclude real differences between the regimens. | applies to atherosclerotic carotid stenosis treated with carotid artery stenting with concurrent non-valvular atrial fibrillation in adults, outpatient settings | it recommends dual antiplatelet therapy alone as the preferred regimen or advises withholding oral anticoagulation because bleeding was numerically lowest | A strong answer conveys: Major bleeding within the first three months did not differ significantly between dual antiplatelet therapy, single antiplatelet plus oral anticoagulation, and triple therapy; Major bleeding was numerically least frequent with dual antiplatelet therapy alone and most frequent with triple therap... | 10.1177/15385744251387547 | paywalled |
steered/10.1007/s00392-025-02702-8 | cardiology | What is known about outcomes after tricuspid transcatheter edge-to-edge repair in the very elderly? | [
"The very elderly, the oldest patients treated, reach two-year survival after tricuspid edge-to-edge repair comparable to that of the youngest, so older age at intervention is not associated with worse survival",
"Survival free from heart failure hospitalisation is similar irrespective of age at intervention, inc... | The evidence is an observed comparison across age groups in routine practice with no untreated comparison group, so comparable outcomes with advancing age are a consistent pattern rather than proven equivalence or a demonstrated benefit of the procedure. | applies to significant tricuspid regurgitation treated with transcatheter edge-to-edge repair in older adults, including the very elderly, outpatient settings | it states that age can be disregarded in selection so that the procedure should be offered to any very elderly patient irrespective of comorbidity, symptoms, anatomy and expected life expectancy | A strong answer conveys: The very elderly, the oldest patients treated, reach two-year survival after tricuspid edge-to-edge repair comparable to that of the youngest, so older age at intervention is not associated with worse survival; Survival free from heart failure hospitalisation is similar irrespective of age at i... | 10.1007/s00392-025-02702-8 | open |
steered/10.1002/clc.70247 | cardiology | How does the Naples Prognostic Score relate to mortality in acute coronary syndrome patients undergoing PCI? | [
"A high Naples Prognostic Score is associated with higher all-cause mortality after percutaneous coronary intervention for acute coronary syndrome, on the order of a two-fold difference between high and low score groups (pooled risk ratio about 0.42 for low versus high)",
"Pooled comparisons of high versus low sc... | The association with all-cause mortality is consistent and quantified but reflects observed differences between patient groups rather than the effect of any assigned treatment, while the in-hospital mortality estimate is too heterogeneous to be relied upon. | applies to acute coronary syndrome treated with percutaneous coronary intervention in adults, inpatient settings | it states that treating the nutritional or inflammatory components of the score lowers the score and thereby reduces death | A strong answer conveys: A high Naples Prognostic Score is associated with higher all-cause mortality after percutaneous coronary intervention for acute coronary syndrome, on the order of a two-fold difference between high and low score groups (pooled risk ratio about 0.42 for low versus high); Pooled comparisons of hi... | 10.1002/clc.70247 | open |
steered/10.1111/jce.70139 | cardiology | Which clinical and procedural factors identify patients at risk of permanent pacemaker implantation after valve-in-valve TAVR? | [
"Pre-procedural bifascicular block is associated with higher odds of permanent pacemaker implantation after valve-in-valve transcatheter aortic valve replacement",
"Greater septal implantation depth of the transcatheter valve is associated with higher odds of permanent pacemaker implantation",
"New left or righ... | The findings show associations rather than proven causes, and because pacemaker events were few the estimates are imprecise. | applies to degenerated bioprosthetic aortic valve treated with valve-in-valve transcatheter replacement in adults, inpatient settings | it presents the choice of transcatheter valve type as an established predictor of, or a way to prevent, pacemaker need after valve-in-valve replacement | A strong answer conveys: Pre-procedural bifascicular block is associated with higher odds of permanent pacemaker implantation after valve-in-valve transcatheter aortic valve replacement; Greater septal implantation depth of the transcatheter valve is associated with higher odds of permanent pacemaker implantation; New ... | 10.1111/jce.70139 | paywalled |
steered/10.1007/s11357-025-02026-5 | cardiology | How do multimorbidity, frailty and polypharmacy relate to death or major adverse cardiovascular events in atrial fibrillation? | [
"Multimorbidity, frailty and polypharmacy are each associated with a higher risk of the composite of all-cause death and major adverse cardiovascular events after adjustment for confounders",
"Crude rates of the composite outcome rise stepwise across patients fulfilling zero, one, two or three of these complexity... | The required claims rest on associations that hold consistently across each complexity domain and strengthen as the number of domains rises within a large analysed population, so they support correlation rather than established cause and effect. | applies to atrial fibrillation in adults, mixed settings | it asserts that reducing the number of medications or reversing frailty has been shown to lower the risk of death or major adverse cardiovascular events | A strong answer conveys: Multimorbidity, frailty and polypharmacy are each associated with a higher risk of the composite of all-cause death and major adverse cardiovascular events after adjustment for confounders; Crude rates of the composite outcome rise stepwise across patients fulfilling zero, one, two or three of ... | 10.1007/s11357-025-02026-5 | open |
steered/10.1007/s00392-025-02755-9 | cardiology | How does TAVI with PCI compare with SAVR plus CABG for mortality in aortic stenosis with coronary disease? | [
"All-cause mortality through three years is similar after combined transcatheter valve implantation with percutaneous revascularization and after combined surgical valve replacement with bypass grafting, with no statistically significant difference in matched comparisons",
"Deaths are nonetheless numerically fewe... | Because the mortality comparison draws on groups balanced by matching rather than by chance allocation, and the reference dataset supplies no significance testing itself, the evidence indicates outcomes are comparable rather than demonstrating true equivalence, while signals for later survival remain inconsistent. | applies to severe aortic stenosis with concomitant coronary artery disease in elderly adults, inpatient settings | it states that the percutaneous strategy has been shown to give equivalent survival in patients with left main or complex multivessel coronary disease | A strong answer conveys: All-cause mortality through three years is similar after combined transcatheter valve implantation with percutaneous revascularization and after combined surgical valve replacement with bypass grafting, with no statistically significant difference in matched comparisons; Deaths are nonetheless ... | 10.1007/s00392-025-02755-9 | open |
steered/10.1111/jce.70075 | cardiology | How does catheter ablation compare with antiarrhythmic drug therapy plus a defibrillator for outcomes in ischemic ventricular tachycardia? | [
"Compared with antiarrhythmic drug therapy plus a defibrillator, catheter ablation of ventricular tachycardia does not reduce all-cause mortality",
"Compared with antiarrhythmic drug therapy plus a defibrillator, ablation does not reduce ventricular tachycardia or fibrillation recurrence",
"Ablation showed no s... | Evidence combined across multiple high-quality controlled comparisons with random allocation shows no difference between ablation and drug therapy plus a defibrillator, but these null findings indicate an absence of demonstrated benefit rather than established equivalence. | applies to ventricular tachycardia in ischemic heart disease with an implantable defibrillator in adults, predominantly older men, mixed settings | it treats the absence of a mortality difference as proven equivalence between ablation and antiarrhythmic drug therapy, or as settled survival evidence that requires no further data | A strong answer conveys: Compared with antiarrhythmic drug therapy plus a defibrillator, catheter ablation of ventricular tachycardia does not reduce all-cause mortality; Compared with antiarrhythmic drug therapy plus a defibrillator, ablation does not reduce ventricular tachycardia or fibrillation recurrence; Ablation... | 10.1111/jce.70075 | paywalled |
steered/10.1177/08850666251405856 | cardiology | How does pulmonary artery catheter use relate to in-hospital mortality among ICU patients with cardiogenic shock? | [
"In propensity-matched and inverse-probability-weighted analyses of intensive care data, and in pooled observational reports, pulmonary artery catheter use was associated with lower in-hospital mortality, whereas randomised trials in critically ill patients did not demonstrate a mortality benefit, so the direction ... | The survival signal rests on statistically adjusted comparisons of care as it happened to be delivered and has not been confirmed by evidence in which treatment was allocated by chance, so it remains unsettled rather than established. | applies to cardiogenic shock in adults aged 18 years and older receiving critical care, inpatient settings | it concludes that pulmonary artery catheters offer no benefit and should be withheld in cardiogenic shock caused by acute coronary syndrome | A strong answer conveys: In propensity-matched and inverse-probability-weighted analyses of intensive care data, and in pooled observational reports, pulmonary artery catheter use was associated with lower in-hospital mortality, whereas randomised trials in critically ill patients did not demonstrate a mortality benefi... | 10.1177/08850666251405856 | paywalled |
steered/10.1002/mus.70121 | neuroimmunology | Which clinical features characterize anti-neurofascin antibody-associated neuropathies across acute and chronic presentations? | [
"Chronic presentations commonly show sensorimotor weakness, sensory ataxia, tremor and a fluctuating course",
"Acute presentations are typically motor-predominant, severe at onset and progress rapidly to nadir",
"The phenotype spans acute, chronic and recurrent acute presentations rather than a single stereotyp... | The supporting evidence is preliminary: it comes from a small number of patients described without a comparison group at a single site, so these patterns should be treated as tentative rather than confirmed. | applies to anti-neurofascin antibody-associated neuropathy in adults and adolescents, mixed settings | it asserts that each individual nodal or paranodal antibody specificity maps to a distinct, predictable clinical syndrome | A strong answer conveys: Chronic presentations commonly show sensorimotor weakness, sensory ataxia, tremor and a fluctuating course; Acute presentations are typically motor-predominant, severe at onset and progress rapidly to nadir; The phenotype spans acute, chronic and recurrent acute presentations rather than a sing... | 10.1002/mus.70121 | paywalled |
steered/10.1136/jnnp-2025-337039 | neuroimmunology | Which laboratory biomarkers relate to relapse risk in patients with MOG antibody-associated disease? | [
"Persistent MOG-IgG seropositivity on repeat serum sampling is associated with a relapsing rather than monophasic disease course, with roughly threefold higher odds",
"A relapsing course is associated with a much lower likelihood of seroreverting to MOG-IgG negative status, so sustained loss of the antibody track... | These are moderate-strength associations rather than demonstrated causes of relapse, and the supporting data are inconsistent enough to keep the size of the effect approximate. | applies to MOG antibody-associated disease in adults and children, outpatient settings | it advises starting, continuing or stopping long-term immunotherapy on the basis of antibody serostatus or titre alone | A strong answer conveys: Persistent MOG-IgG seropositivity on repeat serum sampling is associated with a relapsing rather than monophasic disease course, with roughly threefold higher odds; A relapsing course is associated with a much lower likelihood of seroreverting to MOG-IgG negative status, so sustained loss of th... | 10.1136/jnnp-2025-337039 | open |
steered/10.1177/08830738251367460 | neuroimmunology | What is known about interferon beta-1a treatment of multiple sclerosis in children and adolescents? | [
"Reports of children and adolescents treated with injectable interferon beta-1a describe reduced relapse rates during treatment",
"Registry experience with these formulations suggests treated children may experience outcomes similar to those seen in adult populations",
"The pegylated formulation was given to fa... | The underlying evidence is uncontrolled and lacks comparison groups, so the findings are best read as provisional signals rather than as an established treatment effect. | applies to multiple sclerosis treated with interferon beta-1a formulations in children and adolescents, outpatient settings | it presents interferon beta-1a as the preferred first-line disease-modifying therapy for children and adolescents with multiple sclerosis generally, or as an approved paediatric option | A strong answer conveys: Reports of children and adolescents treated with injectable interferon beta-1a describe reduced relapse rates during treatment; Registry experience with these formulations suggests treated children may experience outcomes similar to those seen in adult populations; The pegylated formulation was... | 10.1177/08830738251367460 | open |
steered/10.1177/17562864251387930 | neuroimmunology | What is known about anti-CD19 CAR T-cell therapy in stiff-person syndrome spectrum disorder? | [
"In the first reported treated patient with refractory stiff-person syndrome, anti-CD19 CAR T-cell therapy was followed by increased mobility and reduced symptomatic medication use",
"Deep CD19-directed depletion of B-cells and plasmablasts is the proposed rationale, most directly in glycine receptor antibody dis... | The clinical evidence rests on a single reported treated patient with no comparison group, so benefit is suggested rather than demonstrated. | applies to stiff-person syndrome spectrum disorder in adults, inpatient settings | it recommends anti-CD19 CAR T-cell therapy as initial immunotherapy for newly diagnosed disease in place of established first-line treatment | A strong answer conveys: In the first reported treated patient with refractory stiff-person syndrome, anti-CD19 CAR T-cell therapy was followed by increased mobility and reduced symptomatic medication use; Deep CD19-directed depletion of B-cells and plasmablasts is the proposed rationale, most directly in glycine recep... | 10.1177/17562864251387930 | open |
steered/10.1136/bmjno-2025-001252 | neuroimmunology | What distinguishes tumefactive demyelinating lesions with MOG or NMDAR antibodies from those without such antibodies? | [
"MOG antibody-positive patients showed a more inflammatory cerebrospinal fluid profile, with higher white cell counts, than antibody-negative patients",
"MOG antibody-positive lesions more often shrank or disappeared on repeat MRI than antibody-negative lesions",
"NMDAR antibody-positive patients showed higher ... | These are preliminary signals from very small antibody-defined subgroups rather than established discriminators. | applies to tumefactive demyelinating lesions stratified by MOG and NMDAR antibody status in adults, inpatient settings | it asserts that NMDAR antibody positivity here indicates an underlying teratoma that must be resected | A strong answer conveys: MOG antibody-positive patients showed a more inflammatory cerebrospinal fluid profile, with higher white cell counts, than antibody-negative patients; MOG antibody-positive lesions more often shrank or disappeared on repeat MRI than antibody-negative lesions; NMDAR antibody-positive patients sh... | 10.1136/bmjno-2025-001252 | open |
steered/10.1177/13524585261424125 | neuroimmunology | What do visual evoked potentials contribute to the paraclinical workup of suspected optic neuritis under the 2022 ICON criteria? | [
"Visual evoked potentials detected optic nerve involvement in suspected optic neuritis with high overall diagnostic accuracy in the reported series",
"Adding visual evoked potentials as a further paraclinical test to the 2022 ICON criteria improved the sensitivity of the criteria in the reported series",
"An ab... | The accuracy estimates remain provisional, derived from a small patient sample scored against an expert reference diagnosis and not yet reproduced independently. | applies to suspected optic neuritis assessed under the 2022 ICON criteria in adults, mixed settings | it states that a normal visual evoked potential rules out optic neuritis or removes the need for further assessment | A strong answer conveys: Visual evoked potentials detected optic nerve involvement in suspected optic neuritis with high overall diagnostic accuracy in the reported series; Adding visual evoked potentials as a further paraclinical test to the 2022 ICON criteria improved the sensitivity of the criteria in the reported s... | 10.1177/13524585261424125 | open |
steered/10.1007/s00109-025-02616-y | neuroimmunology | What is known about candidate bacterial antigens targeted by intrathecally produced cerebrospinal fluid antibodies in demyelinating disease? | [
"The candidate antigens are whole lysates of twenty bacteria, not defined proteins, the panel drawn from organisms that earlier brain-tissue sequencing had named as multiple sclerosis candidates, and against that panel spinal fluid IgG from some subjects with demyelinating disease reacted with commensal gut and gen... | The evidence comes from very few subjects with no formal comparison between the disease groups, so these are preliminary observations rather than established antigen targets. | applies to multiple sclerosis and other demyelinating diseases in adults with paired spinal fluid and serum samples, mixed settings | it presents bacterial antibody index testing as able to distinguish demyelinating disease from other neurologic conditions | A strong answer conveys: The candidate antigens are whole lysates of twenty bacteria, not defined proteins, the panel drawn from organisms that earlier brain-tissue sequencing had named as multiple sclerosis candidates, and against that panel spinal fluid IgG from some subjects with demyelinating disease reacted with c... | 10.1007/s00109-025-02616-y | open |
steered/10.1007/s40120-026-00906-2 | neuroimmunology | What is known about clinical outcomes with lorazepam or immunoglobulin therapy compared with no therapy in DSRD? | [
"Immunoglobulin therapy is associated with greater improvement than no therapy across the assessed motor, catatonia, global severity and neuropsychiatric measures",
"Lorazepam is associated with greater improvement than no therapy on most, but not all, of the assessed outcome measures",
"Immunoglobulin therapy ... | The evidence is moderately strong and consistent across the assessed outcome measures but supports association rather than a proven treatment effect, and the timing pattern within the lorazepam arm is a weaker within-group observation. | applies to DSRD in children and young adults, outpatient settings | it states that these data establish how long immunoglobulin therapy should be continued or when it can be safely withdrawn | A strong answer conveys: Immunoglobulin therapy is associated with greater improvement than no therapy across the assessed motor, catatonia, global severity and neuropsychiatric measures; Lorazepam is associated with greater improvement than no therapy on most, but not all, of the assessed outcome measures; Immunoglobu... | 10.1007/s40120-026-00906-2 | open |
steered/10.1177/17562864251377559 | neuroimmunology | What is known about anti-Yo antibody-positive neurological disorders in patients receiving immune checkpoint inhibitor therapy? | [
"In the few reported patients the associated tumours differed from the ovarian serous and breast cancers classically linked to anti-Yo antibodies, including ovarian clear cell carcinoma, uterine cancer and a lung tumour",
"Rapidly progressive cerebellar syndrome was among the neurological presentations described"... | The evidence comes from a handful of individually described patients without a comparison group, so these are preliminary observations rather than established patterns. | applies to immune checkpoint inhibitor-related neurological disorders with anti-Yo antibodies in adults with solid tumours, mixed settings | it states that checkpoint inhibitor treatment can be safely continued or resumed once these neurological symptoms have appeared | A strong answer conveys: In the few reported patients the associated tumours differed from the ovarian serous and breast cancers classically linked to anti-Yo antibodies, including ovarian clear cell carcinoma, uterine cancer and a lung tumour; Rapidly progressive cerebellar syndrome was among the neurological presenta... | 10.1177/17562864251377559 | open |
steered/10.1177/13524585261425076 | neuroimmunology | What is known about the safety of starting ravulizumab in AQP4-antibody-positive NMOSD after prior rituximab treatment? | [
"Treatment-emergent and serious adverse event burden during ravulizumab was similar in rituximab-exposed and rituximab-naive patients, with no signal of added risk from prior rituximab",
"Most adverse events in both subgroups were mild or moderate, with severe events affecting only a minority of patients",
"Dea... | Event counts are small and come from an uncontrolled, non-comparative safety summary, so comparable safety is a tentative observation rather than established equivalence. | applies to AQP4-antibody-positive NMOSD with prior rituximab treatment in adults, outpatient settings | it claims that prior rituximab exposure lowers adverse-event risk during ravulizumab | A strong answer conveys: Treatment-emergent and serious adverse event burden during ravulizumab was similar in rituximab-exposed and rituximab-naive patients, with no signal of added risk from prior rituximab; Most adverse events in both subgroups were mild or moderate, with severe events affecting only a minority of p... | 10.1177/13524585261425076 | open |
steered/10.1111/jce.70170 | cardiology | How do periprocedural complications after transvenous lead extraction of cardiac implantable electronic devices differ between men and women? | [
"Women undergoing transvenous lead extraction have modestly higher odds of cardiac and pulmonary complications than men, including pericardial effusion, tamponade, pneumothorax and hemothorax",
"In-hospital mortality did not differ significantly between women and men, whereas a prior single-centre series reported... | The evidence supports a consistent association between sex and complication rates rather than a demonstrated cause, and the mortality comparison is unsettled across reports. | applies to cardiac implantable electronic device-related indications requiring transvenous lead extraction in adults, inpatient settings | it presents female sex as a demonstrated cause of extraction complications or recommends deferring, restricting or otherwise altering extraction in women on this basis | A strong answer conveys: Women undergoing transvenous lead extraction have modestly higher odds of cardiac and pulmonary complications than men, including pericardial effusion, tamponade, pneumothorax and hemothorax; In-hospital mortality did not differ significantly between women and men, whereas a prior single-centre... | 10.1111/jce.70170 | paywalled |
steered/10.1177/27683605251392469 | cardiology | What outcomes follow Baduanjin exercise added to cardiac rehabilitation in patients with chronic heart failure? | [
"Adding Baduanjin exercise to conventional heart-failure medication is associated with higher left ventricular ejection fraction, longer six-minute walk distance and better quality of life than conventional medication with other exercise methods",
"Depression scores were also lower with added Baduanjin exercise, ... | Confidence in the pooled outcomes is low to moderate, constrained by serious to very serious inconsistency across the contributing evidence and by allocation concealment and blinding that were largely unreported, so the findings are best read as suggestive rather than established. | applies to chronic heart failure in adults, outpatient settings | it presents Baduanjin as an established substitute for conventional exercise-based cardiac rehabilitation or recommends replacing standard exercise training on this basis | A strong answer conveys: Adding Baduanjin exercise to conventional heart-failure medication is associated with higher left ventricular ejection fraction, longer six-minute walk distance and better quality of life than conventional medication with other exercise methods; Depression scores were also lower with added Badu... | 10.1177/27683605251392469 | paywalled |
steered/10.1136/heartjnl-2025-326197 | cardiology | What does coronary inflammation measured on routine CT angiography add to risk assessment in non-obstructive coronary artery disease? | [
"Higher coronary inflammation measured as perivascular fat attenuation on routine coronary CT angiography is associated with a higher rate of later cardiovascular events, including in patients whose arteries show only non-obstructive disease",
"Adding the perivascular attenuation measure to conventional assessmen... | The added value rests on observed associations between the imaging measure and later events rather than on any demonstrated causal or treatment effect. | applies to non-obstructive coronary artery disease on coronary CT angiography in adults having clinically indicated coronary imaging, outpatient settings | it presents a low coronary inflammation value as established grounds for withholding, stopping or de-escalating preventive therapy in patients who otherwise meet treatment criteria | A strong answer conveys: Higher coronary inflammation measured as perivascular fat attenuation on routine coronary CT angiography is associated with a higher rate of later cardiovascular events, including in patients whose arteries show only non-obstructive disease; Adding the perivascular attenuation measure to conven... | 10.1136/heartjnl-2025-326197 | paywalled |
steered/10.1177/10872914261473689 | cardiology | How do outcomes after acute coronary syndrome in people with HIV compare with those without HIV? | [
"One-year mortality after acute coronary syndrome did not differ appreciably between people with and without HIV",
"New cardiovascular events after acute coronary syndrome, mainly repeat revascularization and recurrent acute coronary syndrome, were numerically more frequent in people with HIV",
"The hazard comp... | The evidence is weak and imprecise: too few people with HIV were compared for the comparable outcomes to establish equivalence, and the imprecise event comparison sits alongside pooled results suggesting a small excess. | applies to acute coronary syndrome in adults with and without HIV, mixed settings | it treats the comparable one-year outcomes as established equivalence and concludes that people with HIV need no additional cardiovascular surveillance or secondary prevention after acute coronary syndrome | A strong answer conveys: One-year mortality after acute coronary syndrome did not differ appreciably between people with and without HIV; New cardiovascular events after acute coronary syndrome, mainly repeat revascularization and recurrent acute coronary syndrome, were numerically more frequent in people with HIV; The... | 10.1177/10872914261473689 | paywalled |
steered/10.1136/heartjnl-2025-326186 | cardiology | Which hypertension subtypes are appropriate candidates for renal denervation in current practice? | [
"Guidelines recommend renal denervation as an adjunct therapy for adults with uncontrolled or resistant hypertension in whom other means have failed or given insufficient blood pressure control",
"Candidate selection, including the patient's own preference, is settled through a shared decision-making process befo... | The blood pressure effect rests on blinded sham-controlled comparisons of modest size, while candidacy and the selection process reflect guideline consensus rather than a tested effect. | applies to uncontrolled or resistant hypertension in adults, outpatient settings | it presents long-term durability of the blood pressure reduction as established by controlled comparison, or recommends the procedure primarily on the strength of a permanent effect | A strong answer conveys: Guidelines recommend renal denervation as an adjunct therapy for adults with uncontrolled or resistant hypertension in whom other means have failed or given insufficient blood pressure control; Candidate selection, including the patient's own preference, is settled through a shared decision-mak... | 10.1136/heartjnl-2025-326186 | paywalled |
steered/10.1177/20480040261445493 | cardiology | What survival outcomes follow post-cardiotomy venoarterial extracorporeal membrane oxygenation for failure to wean from cardiopulmonary bypass? | [
"About half of adults supported for failure to wean from cardiopulmonary bypass survived to hospital discharge, with in-hospital death in the remainder",
"This survival level was in keeping with the roughly 30% to 50% survival reported in earlier postcardiotomy extracorporeal support series",
"Among survivors, ... | Evidence strength is low, resting on uncontrolled proportions from a small, narrowly sourced group of patients, so the findings describe outcomes rather than demonstrate benefit. | applies to postcardiotomy cardiogenic shock with failure to wean from cardiopulmonary bypass in adults, inpatient settings | it presents this experience as demonstrating that extracorporeal support improves survival compared with alternative circulatory support strategies | A strong answer conveys: About half of adults supported for failure to wean from cardiopulmonary bypass survived to hospital discharge, with in-hospital death in the remainder; This survival level was in keeping with the roughly 30% to 50% survival reported in earlier postcardiotomy extracorporeal support series; Among... | 10.1177/20480040261445493 | paywalled |
steered/10.1007/s00392-025-02784-4 | cardiology | What key clinical outcomes follow finerenone therapy in patients with heart failure and left ventricular ejection fraction above 40%? | [
"Finerenone added to standard therapy reduces the composite of cardiovascular death and worsening heart failure events (heart failure hospitalisation or emergency visits) in heart failure with ejection fraction above 40%",
"The size of that composite effect is modest: about a 16% relative risk reduction, with an ... | The direction of benefit on the composite endpoint and on heart failure hospitalisations rests on a single large placebo-controlled comparison in which treatment was allocated by chance, with estimates relayed without confidence intervals, while the cardiovascular mortality component on its own did not reach statistica... | applies to heart failure with mildly reduced or preserved ejection fraction (ejection fraction above 40%) in adults on standard background therapy, mixed settings | it presents finerenone as an established therapy for heart failure with reduced ejection fraction, or as demonstrated across the whole ejection fraction range | A strong answer conveys: Finerenone added to standard therapy reduces the composite of cardiovascular death and worsening heart failure events (heart failure hospitalisation or emergency visits) in heart failure with ejection fraction above 40%; The size of that composite effect is modest: about a 16% relative risk red... | 10.1007/s00392-025-02784-4 | open |
steered/10.1007/s12181-026-00807-6 | cardiology | Which pharmacological therapies are currently recommended for patients with heart failure with preserved ejection fraction? | [
"Sodium-glucose cotransporter 2 inhibition with empagliflozin or dapagliflozin reduces the composite of worsening heart failure and cardiovascular death, a benefit carried by about 21-27% fewer heart failure hospitalisations",
"Finerenone reduces the composite of total heart failure events and cardiovascular deat... | Both the benefit and the non-benefit claims rest on comparisons in which treatment was allocated by chance rather than chosen, although the sodium-glucose cotransporter 2 inhibitor evidence came from participants spanning preserved together with mildly reduced ejection fraction, leaving the share attributable to preser... | applies to heart failure with preserved ejection fraction in adults, outpatient settings | it presents a reduction in death rates with these drug classes as demonstrated in preserved ejection fraction, or recommends them on that basis | A strong answer conveys: Sodium-glucose cotransporter 2 inhibition with empagliflozin or dapagliflozin reduces the composite of worsening heart failure and cardiovascular death, a benefit carried by about 21-27% fewer heart failure hospitalisations; Finerenone reduces the composite of total heart failure events and car... | 10.1007/s12181-026-00807-6 | open |
steered/10.1177/02841851261418633 | cardiology | Which cardiovascular magnetic resonance parameters identify acute myocarditis in patients with clinically suspected disease? | [
"Global native T1, global T2 and extracellular volume fraction are each higher in acute myocarditis than in healthy comparison subjects",
"Extracellular volume fraction separated myocarditis from healthy comparison subjects more sharply than native T1 or T2 alone",
"The updated two-out-of-two Lake Louise criter... | Support remains preliminary: the group differences look consistent, but the accuracy estimates come from a small sample gathered at a single hospital on one scanner, with thresholds fitted on the same participants in whom they were then evaluated. | applies to clinically suspected acute myocarditis in adults, inpatient settings | it presents left ventricular ejection fraction or chamber volumes as established markers for identifying acute myocarditis, or recommends relying on them to make or exclude the diagnosis | A strong answer conveys: Global native T1, global T2 and extracellular volume fraction are each higher in acute myocarditis than in healthy comparison subjects; Extracellular volume fraction separated myocarditis from healthy comparison subjects more sharply than native T1 or T2 alone; The updated two-out-of-two Lake L... | 10.1177/02841851261418633 | paywalled |
steered/10.1136/bmjdh-2026-000053 | cardiology | What is known about the clinical value of AI-derived coronary artery calcium scores for cardiovascular risk prognostication? | [
"AI-derived coronary artery calcium from chest CT is consistently associated with all-cause mortality, cardiovascular mortality, major adverse cardiovascular events and obstructive coronary artery disease across varied patient groups and imaging indications",
"Early prospective and implementation-focused experien... | The evidence supports consistent associations with death and cardiovascular events rather than demonstrated benefit, while the workflow engagement and efficiency signals rest on early, methodologically varied, and largely low-strength sources. | applies to cardiovascular risk prognostication using AI-derived coronary artery calcium in adults undergoing non-gated chest CT for cardiovascular and non-cardiovascular indications, mixed settings | it presents automated coronary artery calcium scoring as an established, cost-effective component of preventive cardiology that should be switched on as standard of care for every chest CT | A strong answer conveys: AI-derived coronary artery calcium from chest CT is consistently associated with all-cause mortality, cardiovascular mortality, major adverse cardiovascular events and obstructive coronary artery disease across varied patient groups and imaging indications; Early prospective and implementation-... | 10.1136/bmjdh-2026-000053 | open |
steered/10.1007/s10554-026-03658-0 | cardiology | Which exercise stress parameters stratify risk of major adverse cardiovascular events after a normal exercise SPECT myocardial perfusion study? | [
"A stress rate pressure product at peak exercise below the conventional threshold of about 25,000 is associated with more cardiac events, independently of the other exercise parameters tested",
"A low Duke treadmill score is likewise associated with more cardiac events after a normal exercise perfusion study",
... | The risk gradients are moderate-strength observed associations from a single large clinical sample with few events, and the non-significant parameters are underpowered nulls rather than established negatives. | applies to known or suspected coronary artery disease with a normal exercise SPECT myocardial perfusion study in adults able to complete a treadmill or bicycle protocol, outpatient settings | it presents ischemic exercise ECG changes accompanying a normal perfusion study as an established marker of higher event risk or recommends further testing on that basis | A strong answer conveys: A stress rate pressure product at peak exercise below the conventional threshold of about 25,000 is associated with more cardiac events, independently of the other exercise parameters tested; A low Duke treadmill score is likewise associated with more cardiac events after a normal exercise perf... | 10.1007/s10554-026-03658-0 | open |
steered/10.1002/clc.70329 | cardiology | In which clinical scenarios do ESC guidelines position cardiovascular magnetic resonance as a first-line diagnostic test? | [
"Cardiovascular magnetic resonance is positioned as a first-line, adjudicatory test in scenarios of high diagnostic uncertainty, including myocardial infarction with non-obstructive coronary arteries, suspected cardiomyopathy, sports participation after myocarditis and complex valvular disease",
"In chronic coron... | This describes where guidance places the test rather than showing patient benefit; several of these recommendations rest on Level C evidence and no patient outcomes were compared between imaging strategies. | applies to cardiovascular disease requiring diagnostic cardiac imaging in adults, mixed settings | it presents magnetic resonance-guided pathways as demonstrated to improve patient outcomes such as mortality or repeat admissions | A strong answer conveys: Cardiovascular magnetic resonance is positioned as a first-line, adjudicatory test in scenarios of high diagnostic uncertainty, including myocardial infarction with non-obstructive coronary arteries, suspected cardiomyopathy, sports participation after myocarditis and complex valvular disease; ... | 10.1002/clc.70329 | open |
steered/10.1136/heartjnl-2025-327108 | cardiology | How well does photon-counting CT detect obstructive coronary stenosis compared with invasive angiography? | [
"Against invasive angiography at a threshold of more than 50% diameter stenosis, pooled sensitivity is high and similar at patient, vessel and segment level (about 95%)",
"Pooled specificity is lowest when whole patients are classified (about 82%) and rises at the vessel (about 89%) and segment (about 95%) levels... | Accuracy against the invasive standard is consistently high across the available studies, but the pooled figures come from ten study-level datasets with moderate heterogeneity in specificity, and non-independent vessel- and segment-level data may overestimate their precision. | applies to suspected obstructive coronary artery stenosis in adults undergoing non-invasive coronary imaging, outpatient settings | it presents photon-counting CT as shown to improve clinical outcomes or cost-effectiveness, or recommends it as a replacement for invasive angiography or as routine surveillance after revascularisation on this basis | A strong answer conveys: Against invasive angiography at a threshold of more than 50% diameter stenosis, pooled sensitivity is high and similar at patient, vessel and segment level (about 95%); Pooled specificity is lowest when whole patients are classified (about 82%) and rises at the vessel (about 89%) and segment (a... | 10.1136/heartjnl-2025-327108 | paywalled |
steered/10.1136/heartjnl-2026-327843 | cardiology | How do long-term outcomes after acute coronary syndrome differ among patients presenting with STEMI, NSTEMI and unstable angina? | [
"Among survivors of the first 30 days after acute coronary syndrome, those whose index event was NSTEMI go on to have the highest five-year burden of major adverse cardiovascular events and of death from any cause, exceeding both STEMI and unstable angina",
"Unstable angina survivors are not a low-risk group, the... | The comparison rests on a large and complete body of linked outcome data and is consistent in both sexes, but it shows adjusted associations with presentation type rather than demonstrated effects of it. | applies to acute coronary syndrome (STEMI, NSTEMI or unstable angina) after surviving the first 30 days from the index event in adults, population-based settings | it presents the outcome differences between acute coronary syndrome presentation types as a causal effect of the presentation type, or asserts that early invasive management or intensified secondary prevention abolishes the difference between subtypes | A strong answer conveys: Among survivors of the first 30 days after acute coronary syndrome, those whose index event was NSTEMI go on to have the highest five-year burden of major adverse cardiovascular events and of death from any cause, exceeding both STEMI and unstable angina; Unstable angina survivors are not a low... | 10.1136/heartjnl-2026-327843 | paywalled |
steered/10.1136/heartjnl-2026-327872 | cardiology | How do different classes of antihypertensive drug relate to cardiovascular outcomes in patients with HFmrEF or HFpEF? | [
"Benefit on the composite of cardiovascular death and heart failure hospitalisation is confined to sodium-glucose cotransporter 2 inhibitors, mineralocorticoid receptor antagonists, angiotensin receptor-neprilysin inhibitors and glucagon-like peptide-1 receptor agonists",
"The other classes examined, including AC... | The class-specific benefit rests on comparisons of allocated treatments under controlled assignment, whereas the absence of any relation to the magnitude of blood pressure lowering is an aggregate-level correlation across comparisons, and the mortality findings are formally tested null results. | applies to heart failure with mildly reduced or preserved ejection fraction in older adults with near-normal baseline blood pressure, outpatient settings | it recommends a specific blood pressure target or an intensified blood-pressure-lowering strategy on this basis, or presents the optimal intensity of blood pressure lowering in this population as established | A strong answer conveys: Benefit on the composite of cardiovascular death and heart failure hospitalisation is confined to sodium-glucose cotransporter 2 inhibitors, mineralocorticoid receptor antagonists, angiotensin receptor-neprilysin inhibitors and glucagon-like peptide-1 receptor agonists; The other classes examin... | 10.1136/heartjnl-2026-327872 | paywalled |
steered/10.1177/08971900251394069 | cardiology | What outcomes follow interruption of beta-blocker therapy in patients with prior uncomplicated myocardial infarction? | [
"Interrupting long-term beta-blocker therapy in stable patients years after an uncomplicated myocardial infarction did not prove non-inferior to continuing it for a combined outcome of death, recurrent infarction, stroke or cardiovascular hospitalisation, which occurred modestly more often after interruption (rough... | The event outcome and the quality-of-life outcome both come from a single large comparison of assigned treatment groups, so effect language is supportable for each while resting on one such comparison. | applies to prior uncomplicated myocardial infarction with preserved left ventricular function in adults on long-term beta-blocker therapy, outpatient settings | it presents continued beta-blocker therapy as demonstrated to prevent deaths or recurrent infarctions, or presents interruption as an established cause of higher mortality, rather than as failing non-inferiority on a combined event outcome | A strong answer conveys: Interrupting long-term beta-blocker therapy in stable patients years after an uncomplicated myocardial infarction did not prove non-inferior to continuing it for a combined outcome of death, recurrent infarction, stroke or cardiovascular hospitalisation, which occurred modestly more often after... | 10.1177/08971900251394069 | paywalled |
steered/10.1177/00033197251378891 | cardiology | How does the CHA2DS2-VASc score relate to in-hospital mortality in patients presenting with acute myocardial infarction? | [
"A higher CHA2DS2-VASc score at presentation is associated with a higher risk of in-hospital death after acute myocardial infarction",
"This association persists when other admission characteristics are taken into account, so the score carries prognostic information independent of them",
"Used as a single bedsi... | The link between higher scores and greater risk rests on associations drawn from routinely collected hospital records rather than on demonstrated causation, and the score's ability to discriminate in-hospital death is only modest. | applies to acute myocardial infarction managed with coronary angiography and percutaneous coronary intervention in adults, inpatient settings | it treats the score as a causal driver of in-hospital death or asserts that lowering its component risk factors during the index admission reduces in-hospital mortality | A strong answer conveys: A higher CHA2DS2-VASc score at presentation is associated with a higher risk of in-hospital death after acute myocardial infarction; This association persists when other admission characteristics are taken into account, so the score carries prognostic information independent of them; Used as a ... | 10.1177/00033197251378891 | paywalled |
steered/10.1002/clc.70308 | cardiology | What is known about direct oral anticoagulants versus vitamin K antagonists on clinical outcomes in non-valvular atrial fibrillation? | [
"Direct oral anticoagulant use is associated with a lower risk of recurrent cerebrovascular ischemic events than vitamin K antagonist use",
"Direct oral anticoagulant use is also associated with a lower risk of major bleeding than vitamin K antagonist use",
"All-cause mortality did not differ significantly betw... | Support for the lower ischemic-event and major-bleeding risks is of moderate strength and consistent across combined analyses drawing on both experimentally allocated and routine-care comparisons, so residual confounding cannot be excluded, whereas the mortality comparison was too inconsistent across contributing evide... | applies to non-valvular atrial fibrillation requiring long-term oral anticoagulation for stroke prevention in adults, outpatient settings | it presents the ischemic-event advantage as separately demonstrated within specific patient groups such as those anticoagulated around catheter ablation or those with a bioprosthetic heart valve | A strong answer conveys: Direct oral anticoagulant use is associated with a lower risk of recurrent cerebrovascular ischemic events than vitamin K antagonist use; Direct oral anticoagulant use is also associated with a lower risk of major bleeding than vitamin K antagonist use; All-cause mortality did not differ signif... | 10.1002/clc.70308 | open |
steered/10.1177/10815589251384949 | cardiology | What perfusion abnormalities appear on myocardial perfusion scintigraphy in patients with cardiac amyloidosis without obstructive coronary disease? | [
"Abnormal myocardial perfusion findings are common in cardiac amyloidosis, being present in most patients imaged",
"Stress perfusion defects are the main abnormality, with group average summed stress scores only modestly elevated",
"A reversible stress-rest difference component is also present, small in average... | The evidence is early and comes from a small group examined without a comparison population, so these are preliminary observations rather than established diagnostic relationships. | applies to cardiac amyloidosis without obstructive coronary disease in adults undergoing myocardial perfusion imaging, outpatient settings | it presents abnormal perfusion scintigraphy as an established or specific marker of cardiac amyloidosis, or recommends it as a basis for forgoing further evaluation for coronary disease | A strong answer conveys: Abnormal myocardial perfusion findings are common in cardiac amyloidosis, being present in most patients imaged; Stress perfusion defects are the main abnormality, with group average summed stress scores only modestly elevated; A reversible stress-rest difference component is also present, smal... | 10.1177/10815589251384949 | paywalled |
steered/10.1136/heartjnl-2026-327844 | cardiology | What outcomes follow heart transplantation in patients with LMNA-related cardiomyopathy? | [
"Survival at one year and over longer follow-up after heart transplantation for LMNA-related cardiomyopathy did not differ from survival in propensity-matched non-ischaemic dilated cardiomyopathy recipients",
"Deaths concentrated early after transplantation, most first-year deaths occurring during the index inten... | The evidence is early and imprecise, resting on few patients and few deaths, so it supports associations at best rather than settled effects. | applies to LMNA-related cardiomyopathy treated with heart transplantation in adults, inpatient settings | it presents electrical storm before transplantation as an established causal determinant of post-transplant death or recommends deferring or withholding transplantation on that basis | A strong answer conveys: Survival at one year and over longer follow-up after heart transplantation for LMNA-related cardiomyopathy did not differ from survival in propensity-matched non-ischaemic dilated cardiomyopathy recipients; Deaths concentrated early after transplantation, most first-year deaths occurring during... | 10.1136/heartjnl-2026-327844 | paywalled |
Redpine Biomedical QA
179 expert-validated biomedical questions, each written from one paper in the Redpine Science full-text corpus and paired with a gold answer: two to four required claims, a certainty sentence, the population and setting the claims hold for, and one over-claim an answer must not make. It is the expert-validated question set of the preprint Leveraging a four-quadrant approach for evaluating Redpine Science.
The runner, the judges, the run log and the published verdicts are on GitHub: redpine-ai/benchmarks.
from datasets import load_dataset
ds = load_dataset("Redpine-AI/redpine-biomedical-qa", split="test")
Fields
| Field | Meaning |
|---|---|
id |
stable id, steered/ followed by the source paper's DOI |
track |
cardiology (79), neuroimmunology (60), sepsis (20) or immunology (20) |
question |
the question as reviewed |
required_claims |
the claims a strong answer conveys, in gold order (633 in all) |
certainty |
how certain the evidence is |
scope |
the population and setting the claims hold for |
wrong_if |
the over-claim an answer must not make; null for steered/10.1177/15230864251401591 |
gold |
the full answer key as one string; the four fields above are parsed from it |
doi |
the source paper's DOI |
access |
open (105) or paywalled (74), the access class of the source paper |
Every gold reads:
A strong answer conveys: <claim>; <claim>[; <claim>[; <claim>]]. Certainty: <sentence>. Scope: <population and setting>. An answer is wrong if <over-claim>.
Scoring
The benchmark scores an answer per required claim: a fixed judge model marks each claim
stated, contradicted or not_addressed, and the answer gets claim coverage, a
contradiction rate and a correctness score. The judge prompt and the scoring rules are in
judging.md.
Citation
@misc{dorm2026redpine,
title = {Leveraging a four-quadrant approach for evaluating Redpine Science},
author = {Dorm, Filip and Vesterbacka, Leonora},
year = {2026},
eprint = {2610.07937},
archivePrefix = {arXiv},
url = {https://arxiv.org/abs/2610.07937}
}
- Downloads last month
- -